Select a category

CVS Health (CVS) will report third-quarter earnings before the market opens Wednesday after the pharmacy and health-care provider had a rocky October that included a CEO change and layoffs, among other cost-cutting moves.

Despite its roughly 30% drop since the start of the year, the 13 analysts tracked by Visible Alpha remain largely bullish on CVS stock, with nine "buy" ratings and four "hold" ratings. However, the average target price of $68.69 implies that analysts expect CVS to recover some—but not all—of its losses since the start of 2024. The stock closed Monday at $54.65, down 2%.

Revenue is projected to rise to $93.02 billion for the quarter, a bump of about 3.6% year-over-year. But net income is expected to fall by more than 40% to $1.29 billion, or $1.05 per share, according to estimates compiled by Visible Alpha.

CVS reports its latest earnings following a turbulent October, which started with reports that a breakup of its namesake pharmacies and Aetna health insurance provider was being considered after its earnings in the first two quarters of 2024 disappointed and it repeatedly cut profit projections.

Weeks after it was reported that the company met with hedge fund Glenview Capital Management to discuss potential changes to its operations, CVS on Oct. 18 said company veteran David Joyner would take over as chief executive officer (CEO). The company at that time also released preliminary third-quarter earnings per share (EPS) projections of 3 cents to 8 cents and said it would provide new full-year guidance on Wednesday's earnings call.

CVS shares have fallen 19% since mid-October.

Read more on Investopedia

A married father of two has told a lady who questioned why he was wooing her that it doesn’t matter that he is married, a man cannot live by bread alone.

The man has messaged the girl that he wanted her to his girl but she refused because he was married and has two kids but the man said being married doesn’t stop him from having a side chic. The lady then demanded 200k from him but he said it’s too early for that, the lady told him to immediately get off his DM.

Continue reading on Instablog

Shares of fertilizer producer The Mosaic Company (MOS) jumped over 5% on Monday, posting the strongest performance of any stock in the S&P 500 following reports Belarusian President Alexander Lukashenko proposed potash production cuts in an effort to boost prices.

Lukashenko reportedly met Monday with Andrey Rybakov, new chief executive officer (CEO) of Belaruskali, the Eastern European nation's largest potash fertilizer company, and suggested approaching potash producers in Russia to coordinate cutting production of the potassium-rich chemicals and minerals by 10% to 11%.

The move could lead to higher prices, benefitting Mosaic, with Belarus and Russia jointly accounting for around 40% of global potash exports.

Shares of Mosaic climbed 5.4% to finish at $28.33 Monday, though even with Monday's gains, they've lost more than one-fifth of their value since the start of the year.

Mosaic's stock price has been under pressure in recent months, with the company warning in September that "sustained operational challenges"—including electrical equipment failures at two mines in Saskatchewan, Canada—would reduce its potash production and shipment volumes by 200,000 to 300,000 tonnes in the third quarter.

Mosaic is set to report third-quarter results before markets open on Nov. 12.

Read more on Investopedia

TV host Frank Edoho and fans has exchanged views over his response to a follower who claimed to be his lookalike.

One of his fans didn’t like the way Frank responded to the guy who claimed he looked like him and he considered it ins¥ltive but Frank felt he is a f%%l. But the lookalike guy was indifferent about as he saw it as mere sarcasm.

Continue reading on Instablog

Novo Nordisk (NVO), maker of popular weight-loss drugs Ozempic and Wegovy, is set to report third-quarter earnings Wednesday morning, with Wall Street analysts generally bullish on the Danish drugmaker's stock.

Analysts with current ratings tracked by Visible Alpha have six "buy" and five "hold" or equivalent ratings. The average price target for the company's shares on its home stock exchange is 963.36 Danish krone (about $140), about 28% over its Monday close.

The company could face increased competition in the weight-loss market in coming years. Companies like Viking Therapeutics (VKTX) and AstraZeneca (AZN) this week offered new data for their own weight-loss drugs in various stages of clinical trials.

Deutsche Bank analysts said Monday that they believe Novo Nordisk, along with Mounjaro and Zepbound-maker Eli Lilly (LLY), have "built moats" that will make it difficult for other companies to scale production enough to challenge their dominant positions in the weight-loss market.

Analysts expect Novo Nordisk to report 72.17 billion krone ($10.48 billion) in revenue for the quarter, with Ozempic and Wegovy sales projected to rise 28% and 63%, respectively, from the same time last year.

Eli Lilly's results missed estimates last week, with sales of Mounjaro and Zepbound continuing to rise and bolster Lilly's revenue.

Read more on Investopedia

The Harris-Biden matchup is turning Americans into homebodies, according to one hotel chain.

Marriott International (MAR) CFO Kathleen Oberg said the election has curtailed demand to a greater degree than prior election cycles. Marriott has “meaningfully lower” bookings for this week and the next, Oberg said Monday on an earnings call Monday.

“The election impact on U.S. and Canada [revenue per available room] is forecasted to be around negative 300 basis points in November and negative 100 basis points for the quarter, double that of past election cycles,” Oberg said on the call, a transcript of which was made available by AlphaSense. (A basis point is a hundredth of a percentage point.)

Marriott on Monday reported $584 million in profit in the third quarter, down from $752 million a year ago. Diluted earnings per share were $2.07, compared to $2.51 a year prior, the company said. The hotelier’s global revenue per available room, which grew 3% year-over-year in the third quarter, is expected to flatten in the fourth, CEO Anthony Capuano said.

Some other travel and hospitality businesses have said demand was down heading into the presidential election, as Americans vote and await results in the race between Vice President Kamala Harris and former President Donald Trump. 

“What happens during a national election is that people tend to stay home,” Avis Budget Group (CAR) President and CEO Joseph Ferraro said during his company's conference call on Monday.

Read more on Investopedia